- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT04677881
Health Effects of Different Types of Bread (HELFAB)
Health Effects and Consumer Aspects of Different Types of Bread
Study Overview
Detailed Description
The investigators aim to include approximately 20 participants in this randomized controlled double-blind cross-over study lasting for 5 weeks.
All participants will be given bread baked with yeast for a 2 weeks run-in period. The participants will then be randomly assigned to either 1 week intervention with bread baked with yeast or sourdough, before a 1 week wash-out period with yeast bread. During the last 1 week intervention period the participants starting with bread baked with yeast will be given sourdough and vice versa.
Questionnaires (GSRS-IBS, BSC, FFQ), blood samples, and feces samples will be collected before and after the intervention periods.
Study Type
Enrollment (Actual)
Phase
- Not Applicable
Contacts and Locations
Study Locations
-
-
-
Oslo, Norway, 0130
- Vibeke Telle-Hansen
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Genders Eligible for Study
Description
Inclusion Criteria:
- healthy adults who restrict their intake of bread due to stomach ache.
Exclusion Criteria:
- Chronic metabolic diseases, such as diabetes type 1 or 2, cardiovascular diseases and cancer last 6 months
- Gut diseases, including Chron's disease, ulcers colitis
- Food allergies or intolerance
- Pregnant and/or lactating
- Smokers
- BMI <18,5 and >27 kg/m2
- Planed weight reduction and/or ± 5% weight change last 3 months
- Blood donor last 2 months and during the study period
- Not willing to quit taking dietary supplements, including probiotics, cod liver oil etc., 4 weeks prior to study start and during the study
- Use of antibiotics <3 months prior to study start and during the study
- Alcohol intake >40 g/day
- Hormone treatment (except contraceptives)
Study Plan
How is the study designed?
Design Details
- Primary Purpose: Basic Science
- Allocation: Randomized
- Interventional Model: Crossover Assignment
- Masking: Double
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
---|---|
Placebo Comparator: Wholegrain bread with yeast
The control group will be given min.
5 slices of bread baked with yeast per day.
|
intervention group: bread with sourdough control group: bread with yeast
|
Experimental: Wholegrain bread with sourdough
The experimental group will be given min.
5 slices of bread baked with sourdough per day.
|
intervention group: bread with sourdough control group: bread with yeast
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Gastrointestinal Symptom Rating Scale-irritable bowl syndrome (GSRS-IBS)
Time Frame: 5 weeks
|
GSRS-IBS analysis after intervention with bread baked with yeast versus sourdough with the following response scale: 1 (no discomfort at all) to 7 (very severe discomfort)
|
5 weeks
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Bristol stool chart (BSC)
Time Frame: 5 weeks
|
BSC analyses after intervention with bread baked with yeast versus sourdough with a scale from 1 (separate hard lumps, like nuts) to 7 (watery, no solid pieces)
|
5 weeks
|
Blood C-peptide, total cholesterol, triglycerides, fatty acid profile, and short chain fatty acids
Time Frame: 5 weeks
|
Blood analyses of C-peptide, total cholesterol, triglycerides, fatty acid profile, and short chain fatty acids after intervention with bread baked with yeast versus sourdough
|
5 weeks
|
Feces microbiota analysis performed with Bio-Me's Precision Microbiome Profiling platform (PMP™)
Time Frame: 5 weeks
|
Feces analyses of microbiota after intervention with bread baked with yeast versus sourdough
|
5 weeks
|
Iron, selenium and zinc in blood
Time Frame: 5 weeks
|
Blood analysis of iron, selenium and zinc after intervention with bread baked with yeast versus sourdough
|
5 weeks
|
Collaborators and Investigators
Sponsor
Investigators
- Principal Investigator: Vibeke Telle-Hansen, PhD, Oslo and Akershus University College
Study record dates
Study Major Dates
Study Start (Actual)
Primary Completion (Actual)
Study Completion (Actual)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Actual)
Study Record Updates
Last Update Posted (Actual)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Other Study ID Numbers
- 96264
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
Studies a U.S. FDA-regulated device product
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on IBS
-
University of North Carolina, Chapel HillTakeda Pharmaceuticals North America, Inc.CompletedIBS, Diarrhea Predominant | IBS, Constipation Predominant | IBS, Mixed Symptoms
-
National Institute of Diabetes and Digestive and...Completed
-
KU LeuvenRecruitingHealthy Controls | IBS | Ulcerative Colitis, Active | Ulcerative Colitis, Remission (3a: With IBS Symptoms, 3b: Without IBS Symptoms) | Crohn's Disease, Active | Crohn's Disease, Remission (6a: With IBS Symptoms, 6b: Without IBS Symptoms)Belgium
-
Centre Hospitalier de TroyesInstitut National de la Santé Et de la Recherche Médicale, FranceNot yet recruitingOSTEOPATHY IN THE TREATMENT OF IBS SYMPTOMS IN ADULTS
-
Azienda Ospedaliera "Sant'Andrea"Not yet recruitingPediatric | IBS | Bifidobacterium Adolescentis PRL2019
-
Nutrabiotix, LLCRush University Medical CenterTerminatedConstipation-predominant IBS (IBS-C)United States
-
Guy BoeckxstaensFund for Scientific Research, Flanders, BelgiumRecruiting
-
NovartisCompletedIBS-C and IBS With Mixed Bowel Habits
Clinical Trials on Intervention group
-
Muğla Sıtkı Koçman UniversityNot yet recruiting
-
University of LiegeCentre Hospitalier Universitaire de Liege; Bial Foundation; FNRS (Télévie); Fondation...RecruitingPain | Cancer | Fatigue | Cognitive Impairment | Sleep Disturbance | Distress, EmotionalBelgium
-
Hospital de Clinicas de Porto AlegreUnknown
-
University of California, San FranciscoNational Cancer Institute (NCI); Cancer Prevention Institute of CaliforniaCompletedHereditary Breast and Ovarian Cancer Syndrome
-
University of Sao PauloCompletedAnxiety | Self Esteem
-
Haute Ecole de Santé VaudCompletedArthroplasty, Replacement, Knee | Arthroplasty, Replacement, HipSwitzerland
-
Azienda Ospedaliero-Universitaria CareggiRecruiting
-
University of North Carolina, Chapel HillNational Heart, Lung, and Blood Institute (NHLBI)CompletedHeart Diseases | Cardiovascular Diseases
-
University of OxfordOxford Brookes UniversityRecruitingOverweight/Obesity, AdolescentUnited Kingdom
-
Beijing Tsinghua Chang Gung HospitalRecruitingLifestyle Intervention | Non Communicable DiseasesChina